/ Not yet recruitingPhase 1 A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children with Cerebral Palsy
A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy
/ Not yet recruitingPhase 2 A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
/ Active, not recruitingPhase 2 A Randomized Controlled Phase IIa, Two-arm Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome
RegeneCyte (HPC, Cord Blood, hUCB) for treatment in patients with post-COVID.
100 Clinical Results associated with StemCyte Taiwan Co., Ltd
0 Patents (Medical) associated with StemCyte Taiwan Co., Ltd
100 Deals associated with StemCyte Taiwan Co., Ltd
100 Translational Medicine associated with StemCyte Taiwan Co., Ltd